<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105989">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02038062</url>
  </required_header>
  <id_info>
    <org_study_id>Fudickar7</org_study_id>
    <nct_id>NCT02038062</nct_id>
  </id_info>
  <brief_title>Tissue Oxygenation of the Tibial Anterior Muscle After Clamping of the Femoral Artery</brief_title>
  <acronym>NIRSFEM</acronym>
  <official_title>Influence of Sevoflurane Preconditioning on Tissue Oxygenation of the Tibial Anterior Muscle Measured by Near-infrared Spectroscopy After Clamping of the Femoral Artery for Vascular Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Schleswig-Holstein</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Schleswig-Holstein</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ischemic preconditioning is defined as protection from cell damage induced by prolonged
      ischemia by preceding cycles of short ischemia. Hence, ischemic preconditioning could reduce
      ischemic lesion during clamping a femoral artery for vascular surgery. In this prospective,
      randomized pilot study is investigated if clamping of the femoral artery leads to ischemia
      of the calf measurable by near-infrared spectroscopy. In addition to this, the effect of
      sevoflurane preconditioning on ischemia of the calf is measured.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ischemic preconditioning is performed by clamping of the femoral artery for five minutes in
      40 patients. In 20 patients sevoflurane preconditioning is performed five minutes before
      ischemic preconditioning by inducing sevoflurane anesthesia for five minutes. Muscle tissue
      oxygenation is measured bilaterally in the anterior tibial muscle by near-infrared
      spectroscopy (INVOS, SOMANETICS, Troy, Michigan/ USA) during preconditioning and following
      ischemia.Clinically relevant ischemia was defined as a decrease of tissue oxygen saturation
      to 95 % of baseline.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Decrease of tissue oxygen saturation below 95 % of baseline</measure>
    <time_frame>4 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Decrease of tissue oxygen saturation below 95 % of baseline</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Tissue Oxygen Saturation.</condition>
  <arm_group>
    <arm_group_label>Sevoflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sevoflurane Preconditioning</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sevoflurane preconditioning</intervention_name>
    <description>Preconditioning by transient application of sevoflurane</description>
    <arm_group_label>Sevoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:vascular surgery with clamping of a femoral artery. -

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Axel Fudickar, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Schleswig-Holstein, Campus Kiel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein, Campus Kiel</name>
      <address>
        <city>Kiel</city>
        <state>Schleswig-Holstein</state>
        <zip>24105</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 15, 2014</lastchanged_date>
  <firstreceived_date>January 14, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Schleswig-Holstein</investigator_affiliation>
    <investigator_full_name>Axel Fudickar</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
